Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
96.6 CHF | +0.52% |
|
+1.22% | +13.83% |
03/07 | NOVARTIS AG : Berenberg sticks Neutral | ZD |
02/07 | Carisma Therapeutics Notifies Novartis Pharmaceuticals of Terminated Manufacturing, Supply Agreement | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.83% | 22TCr | |
+54.07% | 81TCr | |
+37.22% | 62TCr | |
-7.05% | 35TCr | |
+15.44% | 32TCr | |
+5.72% | 29TCr | |
+14.04% | 24TCr | |
-1.31% | 22TCr | |
+7.42% | 17TCr | |
-3.79% | 16TCr |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Fitch Affirms Novartis Ratings on Leading Position in Innovative Pharmaceutical Sector